These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 18443162)

  • 1. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review.
    Joos S; Miksch A; Szecsenyi J; Wieseler B; Grouven U; Kaiser T; Schneider A
    Thorax; 2008 May; 63(5):453-62. PubMed ID: 18443162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
    Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
    Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
    Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
    Cochrane Database Syst Rev; 2010 May; (5):CD005535. PubMed ID: 20464739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.
    Cates CJ; Schmidt S; Ferrer M; Sayer B; Waterson S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD006922. PubMed ID: 30521673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Jaeschke R; Schmidt S; Ferrer M
    Cochrane Database Syst Rev; 2013 Mar; (3):CD006922. PubMed ID: 23543548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
    Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K
    J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial).
    Keith PK; Koch C; Djandji M; Bouchard J; Psaradellis E; Sampalis JS; Schellenberg RR; McIvor RA
    Can Respir J; 2009; 16 Suppl A(Suppl A):17A-31A. PubMed ID: 19557208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.
    Stelmach I; Ożarek-Hanc A; Zaczeniuk M; Stelmach W; Smejda K; Majak P; Jerzynska J; Anna J
    Pulm Pharmacol Ther; 2015 Apr; 31():42-8. PubMed ID: 25640020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of salmeterol/fluticasone compared with montelukast alone (or add-on therapy to fluticasone) in the treatment of bronchial asthma in children and adolescents: a systematic review and meta-analysis.
    Zhou XJ; Qin Z; Lu J; Hong JG
    Chin Med J (Engl); 2021 Nov; 134(24):2954-2961. PubMed ID: 34784306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
    Virchow JC
    Chest; 2002 Jun; 121(6):2083-4. PubMed ID: 12065391
    [No Abstract]   [Full Text] [Related]  

  • 16. Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy.
    Allen-Ramey FC; Bukstein D; Luskin A; Sajjan SG; Markson LE
    J Manag Care Pharm; 2006 May; 12(4):310-21. PubMed ID: 16792437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
    Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
    Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ; Jaeschke R
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.
    Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA
    Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.
    Cates CJ; Oleszczuk M; Stovold E; Wieland LS
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD010005. PubMed ID: 23076961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.